Healing & RecoveryLimited ResearchResearch Only — Extreme Caution

Follistatin 344

FST344 / Myostatin Inhibitor · High-affinity binding and sequestration of myostatin (GDF-8), activin A, and activin B; relieves myostatin-mediated inhibition of muscle satellite cell activation; allows unrestricted muscle fiber hypertrophy and hyperplasia

Not medical advice. For educational and research reference only.

Typical Dose

No established safe human dose — research setting only

Route

Injectable

Cycle

Not recommended for repeated use

Storage

2–8°C Refrigerated

What is Follistatin 344?

Follistatin 344 is an isoform of follistatin (FST), a naturally occurring glycoprotein that binds and neutralizes TGF-β superfamily members, most notably myostatin (GDF-8) and activin A. Animal studies show dramatic and permanent muscle hypertrophy with single gene therapy doses. Human pharmacokinetic and safety data are extremely limited; the risk of irreversible muscular hypertrophy and unknown off-target effects make this highly experimental. Research only — extreme caution advised.

Mechanism of Action

High-affinity binding and sequestration of myostatin (GDF-8), activin A, and activin B; relieves myostatin-mediated inhibition of muscle satellite cell activation; allows unrestricted muscle fiber hypertrophy and hyperplasia

Target: Myostatin (GDF-8), Activin A, Activin B, BMP-11

Research Indications

Tissue RepairMost Effective

Demonstrated acceleration of wound healing and soft tissue repair in research

Gut HealthEffective

Research shows beneficial effects on intestinal lining and GI function

Joint SupportEffective

Associated with reduced joint inflammation and improved mobility

Muscle RecoveryModerate

May support faster recovery from muscle strains and exercise stress

Research Protocols

These are commonly discussed research protocols — not medical advice. Consult a healthcare provider before use.

GoalDoseFrequencyRoute
Starting Dose100 mcgOnce dailySubcutaneous injection
Standard Dose250 mcgOnce dailySubcutaneous injection

Peptide & Drug Interactions

Always consult your healthcare provider before combining with other compounds. Use our Interaction Checker for reference.

TB-500 / BPC-157 (stack)Compatible
NSAIDs (Ibuprofen, Naproxen)Caution
CorticosteroidsCaution
AnticoagulantsMonitor
GH SecretagoguesCompatible
NAD+Compatible

How to Reconstitute & Inject

Use bacteriostatic (BAC) water only. Avoid saline — may cause precipitation. Refrigerate and use within 28 days.

  1. 1

    Remove Follistatin 344 vial from refrigeration and allow to reach room temperature (15–20 minutes)

  2. 2

    Clean vial top with alcohol swab and allow to air dry completely

  3. 3

    Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water)

  4. 4

    Inject BAC water slowly down the side of the vial — do not aim directly at the powder

  5. 5

    Gently swirl in circular motions — DO NOT shake vigorously as this degrades the peptide

  6. 6

    Allow 2–3 minutes for full dissolution — solution should be clear and colorless

  7. 7

    Draw calculated dose into an insulin syringe for subcutaneous injection

  8. 8

    Inject into abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy

  9. 9

    Store reconstituted solution refrigerated (2–8°C) and use within 28 days

What to Expect

Week 1–2

Initial anti-inflammatory effects begin. Reduced pain and swelling in target area.

Week 2–4

Improved tissue mobility and reduced discomfort. Early healing acceleration.

Week 4–8

Significant recovery milestones. Stronger tissue repair and functional improvement.

Week 8–12

Near-complete healing in many cases. Improved strength and tissue integrity.

Side Effects & Safety

  • Generally well-tolerated in research settings
  • Mild nausea with higher doses
  • Injection site redness or discomfort
  • Rare: Dizziness or lightheadedness
  • Potential effect on blood pressure (monitor if hypertensive)

FDA Status & Regulatory Info

Research Only — Extreme Caution

Follistatin 344 is an isoform of follistatin (FST), a naturally occurring glycoprotein that binds and neutralizes TGF-β superfamily members, most notably myostatin (GDF-8) and activin A. Animal studies show dramatic and permanent muscle hypertrophy with single gene therapy doses. Human pharmacokinetic and safety data are extremely limited; the risk of irreversible muscular hypertrophy and unknown off-target effects make this highly experimental. Research only — extreme caution advised.

Rx Required: No
503A Ban: No
Telehealth: N/A
Full FDA Status Tracker

Frequently Asked Questions

Research References

External links for education only. We do not control third-party content.

Community-reported data

The information below reflects self-reported experiences from PeptIQ app users. It is not clinical evidence and should not replace professional medical advice.

Community Intelligence

What 6 users report

6 community reports

Positive 100% · Neutral 0% · Negative 0%

Most reported benefits

Recovery
6
Sleep
6
Energy
3

Dose distribution

Median: 50–100 mcg · Most common: 50–100 mcg

0–25
0
25–50
0
50–100
4
100–200
2
200–400
0
400–600
0
600–1000
0
1000–2000
0
2000+
0

Commonly stacked with

Share Your Experience

Rate Follistatin 344 in the PeptIQ app and help the community make informed decisions.

Research purposes only

This page is for educational reference. It is not medical or legal advice. Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.